These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7021592)

  • 1. A human neutrophil-dependent pathway for generation of angiotensin II. Purification of the product and identification as angiotensin II.
    Wintroub BU; Klickstein LB; Watt KW
    J Clin Invest; 1981 Aug; 68(2):484-90. PubMed ID: 7021592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-angiotensin system. Identification of angiotensinogen as the plasma protein substrate of leukocyte cathepsin G.
    Wintroub BU; Klickstein LB; Dzau VJ; Watt KW
    Biochemistry; 1984 Jan; 23(2):227-32. PubMed ID: 6696878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human neutrophil-dependent pathway for generation of angiotensin II: purification and physicochemical characterization of the plasma protein substrate.
    Wintroub BU; Klickstein LB; Kaempfer CE; Austen KF
    Proc Natl Acad Sci U S A; 1981 Feb; 78(2):1204-8. PubMed ID: 6785751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirmation of direct angiotensin formation by kallikrein.
    Maruta H; Arakawa K
    Biochem J; 1983 Jul; 213(1):193-200. PubMed ID: 6555043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical identity of tryptensin with angiotensin.
    Arakawa K; Yuki M; Ikeda M
    Biochem J; 1980 Jun; 187(3):647-53. PubMed ID: 7188420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain endo-oligopeptidase B: a post-proline cleaving enzyme that inactivates angiotensin I and II.
    Greene LJ; Spadaro AC; Martins AR; Perussi De Jesus WD; Camargo AC
    Hypertension; 1982; 4(2):178-84. PubMed ID: 6175571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of a human neutrophil neutral protease. The neutral peptide-generating protease.
    Coblyn JS; Austen KF; Wintroub BU
    J Clin Invest; 1979 May; 63(5):998-1005. PubMed ID: 36407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a human neutrophil angiotension II-generating protease as cathepsin G.
    Tonnesen MG; Klempner MS; Austen KF; Wintroub BU
    J Clin Invest; 1982 Jan; 69(1):25-30. PubMed ID: 6172448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of some new angiotensin II analogs on the reactivity of small arterioles in the mesentery of rat intestine.
    Folwarczna J; Janiec W; Sliwiński L; Paruszewski R
    Pol J Pharmacol Pharm; 1989; 41(6):585-9. PubMed ID: 2485905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and amino acid composition of human angiotensin I.
    Arakawa K; Nakatani M; Minohara A; Nakamura M
    Biochem J; 1967 Sep; 104(3):900-6. PubMed ID: 4292882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neutrophil-dependent pathway for the generation of a neutral peptide mediator. II. Subcellular localization of the neutrophil protease.
    Wintroub BU; Goetzl EJ; Austen KF
    Immunology; 1977 Jul; 33(1):41-9. PubMed ID: 873575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could angiotensin I be produced from a renin substrate by the HIV-1 protease?
    Sharma SK; Evans DB; Hui JO; Heinrikson RL
    Anal Biochem; 1991 Nov; 198(2):363-7. PubMed ID: 1799223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neutrophil-dependent pathway for the generation of a neutral peptide mediator: partial characterization of components and control by alpha-1-antitrypsin.
    Wintroub BU; Goetzl EJ; Austen KF
    J Exp Med; 1974 Sep; 140(3):812-24. PubMed ID: 4547125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric characterization of modifications to angiotensin II by lipid peroxidation products, 4-oxo-2(E)-nonenal and 4-hydroxy-2(E)-nonenal.
    Lee SH; Takahashi R; Goto T; Oe T
    Chem Res Toxicol; 2010 Nov; 23(11):1771-85. PubMed ID: 20977208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of a fetal somatomedin from the sheep: similarity to insulin-like growth factor II.
    Hey AW; Browne CA; Thorburn GD
    Endocrinology; 1988 Jan; 122(1):12-21. PubMed ID: 3335201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II restricted analogs with biological activity in the erythrocytic cycle of Plasmodium falciparum.
    Torres MD; Silva AF; de Souza Silva L; de Sá Pinheiro AA; Oliveira VX
    J Pept Sci; 2015 Jan; 21(1):24-8. PubMed ID: 25420772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A plasma inhibitor of the renin-antirenin reaction and the in vitro generation of angiotensin I.
    Lucas CP; Waldhausl WK; Cohen EL; Berlinger FG; McDonald WJ; Sider RS
    Metabolism; 1975 Feb; 24(2):127-38. PubMed ID: 163425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of angiotensin I in a cyclostome, Lampetra fluviatilis.
    Rankin JC; Watanabe TX; Nakajima K; Broadhead C; Takei Y
    Zoolog Sci; 2004 Feb; 21(2):173-9. PubMed ID: 14993829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue renin: focus on vascular angiotensin formation.
    Hilgers KF; Mann JF
    Arzneimittelforschung; 1993 Feb; 43(2A):198-201. PubMed ID: 8498964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human platelet angiotensin I-processing system. Identification of components and inhibition of angiotensin-converting enzyme by product.
    Snyder RA; Watt KW; Wintroub BU
    J Biol Chem; 1985 Jul; 260(13):7857-60. PubMed ID: 2989263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.